Form 4: Director Jeffrey Porter Receives cbdMD Equity Grant

Director Jeffrey H. Porter was granted 1,572 restricted stock units as compensation for his service on the board of cbdMD, Inc.

Summary

• Director Jeffrey H. Porter acquired 1,572 restricted stock units (RSUs) on April 14, 2026.
• Each RSU represents a contingent right to receive one share of common stock.
• The grant serves as compensation for board services under the company's equity compensation plan.
• The RSUs vest in four equal quarterly installments starting June 30, 2026, through March 31, 2027.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative filing regarding routine director compensation.

Positives

• Alignment of director interests with shareholders through equity-based compensation.
• Grant was approved by the Compensation, Corporate Governance and Nominating Committee, ensuring independent oversight.

Negatives

• None identified; this is a standard director compensation disclosure.

Risks

• General market risks associated with the volatility of cbdMD's common stock price.
• Potential dilution to existing shareholders upon the vesting and issuance of the underlying common stock.

Future Outlook

The filing does not provide forward-looking financial guidance, focusing solely on director equity compensation.

Management Comments

• The grant was approved in advance by the Issuer's Compensation, Corporate Governance and Nominating Committee.

Industry Context

StockSavvy.ai notes that equity-based compensation for board members is a standard corporate governance practice in the consumer goods and wellness sector to ensure long-term alignment between leadership and shareholders.

Comparison to Industry Standards

• The use of quarterly vesting schedules for director equity is consistent with standard corporate governance practices for small-cap public companies.

Stakeholder Impact

• Minimal impact on shareholders; represents standard director remuneration.

Next Steps

• Vesting of restricted stock units on June 30, 2026, September 30, 2026, December 31, 2026, and March 31, 2027.

Key Dates

Keywords

cbdMD, YCBD, Form 4, Insider Trading, Director Compensation, Restricted Stock Units